The move, a bid to make homes more affordable, would be a back-to-future moment for the two mortgage firms. Buying risky ...

One of the most important things anyone can do as they get close to retirement or even start thinking about retirement is to ...

Contrarian investors are betting that bonds will outperform both stocks and gold in coming months. That’s because bond market ...

Wall Street optimism faded as traders digested mixed economic data and took stock of shifting geopolitical risks amid a ...

Bond market stress is rising as debt maturities and refinancing costs surge, led by Japan and a 2026 U.S. refinancing ...

Barron’s consistently favored stocks over bonds for income in the past decade, and we’re sticking with an equity bias for ...

A foundation of portfolio construction has wobbled in recent years, but a top strategist at BlackRock urges investors not to ...

BND remains a buy: 4.3% yield-to-maturity, 5.9-year duration, and attractive value vs. cash. See why I rate the stock a Buy.

There are few more hated stocks than UnitedHealthcare, the biggest health insurer. Among its other well-known problems, the ...

Many investors disparage bonds—with good reason. You have to determine what problems these investments solve and whether ...

If you’re hunting for yield in 2026, emerging market bonds just became more interesting. The iShares J.P. Morgan USD Emerging Markets Bond ETF (NYSEARCA:EMB) offers a 5.5% dividend yield as the asset ...

Shares of banks and other financial institutions rose in anticipation of another banner year for global stock and bond markets. The chairman and chief executive of insurance giant American ...